Goodwin, G. M. et al. Single-dose psilocybin for a treatment-resistant episode of major depression. N. Engl. J. Med. 387, 1637–1648 (2022).
Raison, C. L. et al. Single-dose psilocybin treatment for major depressive disorder: A randomized clinical trial. JAMA 330, 843–853 (2023).
Griffiths, R. R. et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J. Psychopharmacol. (Oxford, England) 30, 1181–1197 (2016).
Carhart-Harris, R. L. et al. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacol. (Berl.) 235, 399–408 (2018).
Mitchell, J. M. et al. MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study. FOC 21, 315–328 (2023).
Von Rotz, R. et al. Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial. eClinicalMedicine 56, 101809 (2023).
Fincham, G. W. et al. High ventilation breathwork practices: An overview of their effects, mechanisms, and considerations for clinical applications. Neurosci. Biobehav. Rev. 155, 105453 (2023).
Bahi, C. et al. Effects of conscious connected breathing on cortical brain activity, mood and state of consciousness in healthy adults. Curr. Psychol. https://doi.org/10.1007/s12144-023-05119-6 (2023).
Banushi, B. et al. Breathwork interventions for adults with clinically diagnosed anxiety disorders: A scoping review. Brain Sci. 13, 256 (2023).
Uthaug, M. V., Mason, N. L., Havenith, M. N., Vancura, M. & Ramaekers, J. G. An experience with Holotropic Breathwork is associated with improvement in non-judgement and satisfaction with life while reducing symptoms of stress in a Czech-speaking population. J. Psychedelic Stud. 5, 176–189 (2021).
Fincham, G. W., Strauss, C., Montero-Marin, J. & Cavanagh, K. Effect of breathwork on stress and mental health: A meta-analysis of randomised-controlled trials. Sci. Rep. 13, 432 (2023).
Lalande, L., Bambling, M., King, R. & Lowe, R. Breathwork: An additional treatment option for depression and anxiety? J. Contemp. Psychother. 42, 113–119 (2012).
Balban, M. Y. et al. Brief structured respiration practices enhance mood and reduce physiological arousal. CR Med. 0, 100895 (2023).
de Wit, P. A. J. M. & Moraes Cruz, R. Treating PTSD with connected breathing: A clinical case study and theoretical implications. Eur. J. Trauma Dissoc. 5, 100152 (2021).
Rhinewine, J. P. & Williams, O. J. Holotropic breathwork: The potential role of a prolonged, voluntary hyperventilation procedure as an adjunct to psychotherapy. J. Altern. Comp. Med. 13, 771–776 (2007).
Bednarczyk, E. M. et al. Hyperventilation-induced reduction in cerebral blood flow: Assessment by positron emission tomography. DICP 24, 456–460 (1990).
Inbar, O., Inbar, O., Zohar, H. & Ofir, D. Physiological responses during a single rebirthing (Breath work) session: Physiological responses during the rebirthing treatment. Med Sci. Discov. 9, 347–354 (2022).
Krapf, R., Caduff, P., Wagdi, P., Stäubli, M. & Hulter, H. N. Plasma potassium response to acute respiratory alkalosis. Kidney Int. 47, 217–224 (1995).
Stäubli, M., Vogel, F., Bärtsch, P., Flückiger, G. & Ziegler, W. H. Hyperventilation-induced changes of blood cell counts depend on hypocapnia. Eur. J. Appl Physiol. Occup. Physiol. 69, 402–407 (1994).
Tercero, J. et al. Effects on cerebral blood flow of position changes, hyperoxia, CO2 partial pressure variations and the Valsalva manoeuvre: A study in healthy volunteers. Eur. J. Anaesthesiol. 38, 49–57 (2021).
Kox, M. et al. Voluntary activation of the sympathetic nervous system and attenuation of the innate immune response in humans. Proc. Natl. Acad. Sci. USA 111, 7379–7384 (2014).
Muzik, O., Reilly, K. T. & Diwadkar, V. A. “Brain over body”–A study on the willful regulation of autonomic function during cold exposure. NeuroImage 172, 632–641 (2018).
Zwaag, J., Naaktgeboren, R., van Herwaarden, A. E., Pickkers, P. & Kox, M. The effects of cold exposure training and a breathing exercise on the inflammatory response in humans: A pilot study. Psychosom. Med. 84, 457 (2022).
Nuding, S. C. et al. Functional connectivity in raphé-pontomedullary circuits supports active suppression of breathing during hypocapnic apnea. J. Neurophysiol. 114, 2162–2186 (2015).
Ainslie, P. N. & Duffin, J. Integration of cerebrovascular CO2 reactivity and chemoreflex control of breathing: mechanisms of regulation, measurement, and interpretation. Am. J. Physiol. -Regulatory Integr. Comp. Physiol. 296, R1473–R1495 (2009).
Bullock, T., Giesbrecht, B., Beaudin, A. E., Goodyear, B. G. & Poulin, M. J. Effects of changes in end‐tidal PO 2 and PCO 2 on neural responses during rest and sustained attention. Physiol. Rep. 9, e15106 (2021).
Ito, H., Kanno, I., Ibaraki, M., Hatazawa, J. & Miura, S. Changes in human cerebral blood flow and cerebral blood volume during hypercapnia and hypocapnia measured by positron emission tomography. J. Cereb. Blood Flow. Metab. 23, 665–670 (2003).
Kety, S. S. & Schmidt, C. F. The effects of active and passive hyperventilation on cerebral blood flow, cerebral oxygen consumption, cardiac output, and blood pressure of normal young men 1. J. Clin. Invest. 25, 107–119 (1946).
Kontos, H. A., Wei, E. P., Raper, A. J. & Patterson, J. L. Local mechanism of CO2 action of cat pial arterioles. Stroke 8, 226–229 (1977).
Mueller, S. M., Heistad, D. D. & Marcus, M. L. Total and regional cerebral blood flow during hypotension, hypertension, and hypocapnia. Effect of sympathetic denervation in dogs. Circ. Res. 41, 350–356 (1977).
Szabo, K. et al. Hypocapnia induced vasoconstriction significantly inhibits the neurovascular coupling in humans. J. Neurol. Sci. 309, 58–62 (2011).
Posse, S. et al. In vivo measurement of regional brain metabolic response to hyperventilation using magnetic resonance: Proton echo planar spectroscopic imaging (PEPSI). Magn. Reson. Med 37, 858–865 (1997).
Terekhin, P. & Forster, C. Hypocapnia related changes in pain-induced brain activation as measured by functional MRI. Neurosci. Lett. 400, 110–114 (2006).
Wise, R. et al. Dynamic forcing of end-tidal carbon dioxide and oxygen applied to functional magnetic resonance imaging. J. Cereb. Blood Flow. Metab. J. Int. Soc. Cereb. Blood Flow. Metab. 27, 1521–1532 (2007).
Prugger, J., Derdiyok, E., Dinkelacker, J., Costines, C. & Schmidt, T. T. The Altered States Database: Psychometric data from a systematic literature review. Sci. Data 9, 720 (2022).
Grof, S. The Adventure of Self-Discovery: Dimensions of Consciousness and New Perspectives in Psychotherapy and Inner Exploration (State Univ of New York Pr, New York, NY, 1988).
Grof, S. & Grof, C. Holotropic Breathwork, Second Edition: A New Approach to Self-Exploration and Therapy. (SUNY Press, Albany, 2023).
Havenith, M. & Nemri, A. Atemkraft - Das Breathwork-Handbuch. (Schattauer, 2025).
Studerus, E., Gamma, A. & Vollenweider, F. X. Psychometric evaluation of the altered states of consciousness rating scale (OAV). PLOS ONE 5, e12412 (2010).
Barrett, F. S., Johnson, M. W. & Griffiths, R. R. Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin. J. Psychopharmacol. 29, 1182–1190 (2015).
MacLean, K. A., Leoutsakos, J.-M. S., Johnson, M. W. & Griffiths, R. R. Factor analysis of the mystical experience questionnaire: A study of experiences occasioned by the hallucinogen psilocybin. J. Sci. Study Relig. 51, 721–737 (2012).
Rush, A. J. et al. An evaluation of the quick inventory of depressive symptomatology and the Hamilton rating scale for depression: A sequenced treatment alternatives to relieve depression trial report. Biol. Psychiatry 59, 493–501 (2006).
Tennant, R. et al. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): Development and UK validation. Health Qual. Life Outcomes 5, 63 (2007).
Ali, N. & Nater, U. M. Salivary alpha-amylase as a biomarker of stress in behavioral medicine. Int. J. Behav. Med. 27, 337–342 (2020).
Nater, U. M. & Rohleder, N. Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: Current state of research. Psychoneuroendocrinology 34, 486–496 (2009).
Genser, B., Cooper, P. J., Yazdanbakhsh, M., Barreto, M. L. & Rodrigues, L. C. A guide to modern statistical analysis of immunological data. BMC Immunol. 8, 27 (2007).
Krekelberg, B. klabhub/bayesFactor: Bayes only. Zenodo https://doi.org/10.5281/zenodo.13744717 (2024).
Cohen, J. Statistical Power Analysis for the Behavioral Sciences. (Routledge, 1988).
Fritz, C. O., Morris, P. E. & Richler, J. J. Effect size estimates: Current use, calculations, and interpretation. J. Exp. Psychol. Gen. 141, 2–18 (2012).
Rosenthal, R., Cooper, H. & Hedges, L. & others. Parametric measures of effect size. Handb. Res. Synth. 621, 231–244 (1994).
Keselman, H. J., Algina, J., Lix, L. M., Wilcox, R. R. & Deering, K. N. A generally robust approach for testing hypotheses and setting confidence intervals for effect sizes. Psychol. Methods 13, 110–129 (2008).
Howell, D. C. Statistical Methods for Psychology, 3rd Ed. xviii, 693 (PWS-Kent Publishing Co, Boston, MA, US, 1992).
Agadzhanyan, N. A., Panina, M. I., Kozupitsa, G. S. & Sergeev, O. S. Subjective and neurological manifestations of hyperventilation states of different intensities. Hum. Physiol. 29, 448–452 (2003).
Hirschfeld, T., Prugger, J., Majić, T. & Schmidt, T. T. Dose-response relationships of LSD-induced subjective experiences in humans. Neuropsychopharmacol 48, 1602–1611 (2023).
Liechti, M. E., Dolder, P. C. & Schmid, Y. Alterations of consciousness and mystical-type experiences after acute LSD in humans. Psychopharmacology 234, 1499–1510 (2017).
Bahi, C. et al. Effects of conscious connected breathing on cortical brain activity, mood and state of consciousness in healthy adults. Curr. Psychol. 43, 10578–10589 (2024).
Golden, T. L. et al. Effects of setting on psychedelic experiences, therapies, and outcomes: A rapid scoping review of the literature. Curr. Top. Behav. Neurosci. 56, 35–70 (2022).
Griffiths, R. R., Richards, W. A., Johnson, M. W., McCann, U. D. & Jesse, R. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. J. Psychopharmacol. 22, 621–632 (2008).
Arena, R. & Sietsema, K. E. Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease. Circulation 123, 668–680 (2011).
Brouwer, A. & Carhart-Harris, R. L. Pivotal mental states. J. Psychopharmacol. 35, 319–352 (2021).
Rebecchini, L. Music, mental health, and immunity. Brain Behav. Immun. Health 18, 100374 (2021).
Hartogsohn, I. Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology. J. Psychopharmacol. 30, 1259–1267 (2016).
Enck, P. & Zipfel, S. Placebo effects in psychotherapy: A framework. Front. Psychiatry 10, 456 (2019).
Otte, C. et al. Major depressive disorder. Nat. Rev. Dis. Prim. 2, 1–20 (2016).
Erritzoe, D. et al. Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers. J. Psychopharmacol. 33, 1068–1075 (2019).
Lebedev, A. V. et al. LSD-induced entropic brain activity predicts subsequent personality change. Hum. Brain Mapp. 37, 3203–3213 (2016).
MacLean, K. A., Johnson, M. W. & Griffiths, R. R. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. J. Psychopharmacol. 25, 1453–1461 (2011).
Wagner, M. T. et al. Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy. J. Psychopharmacol. 31, 967–974 (2017).
Goldfried, M. R. The corrective experience: A core principle for therapeutic change. in Transformation in psychotherapy: Corrective experiences across cognitive behavioral, humanistic, and psychodynamic approaches 13–29 (American Psychological Association, Washington, DC, US, 2012). https://doi.org/10.1037/13747-002.
Hill, C. E. et al. Corrective experiences in psychotherapy: Definitions, processes, consequences, and research directions. in Transformation in psychotherapy: Corrective experiences across cognitive behavioral, humanistic, and psychodynamic approaches 355–370 (American Psychological Association, Washington, DC, US, 2012). https://doi.org/10.1037/13747-017.
Straton, D. Catharsis reconsidered. Aust. N. Z. J. Psychiatry 24, 543–551 (1990).
Walther, R. F. E. & van Schie, H. T. ‘Mind-Revealing’ psychedelic states: psychological processes in subjective experiences that drive positive change. Psychoactives 3, 411–436 (2024).
Henschel, A. V., Williams, J. L. & Hardt, M. M. The role of experiential avoidance and emotion regulation in DSM-5 posttraumatic stress symptomatology. J. Loss Trauma 26, 527–539 (2021).
Kumpula, M. J., Orcutt, H. K., Bardeen, J. R. & Varkovitzky, R. L. Peritraumatic dissociation and experiential avoidance as prospective predictors of posttraumatic stress symptoms. J. Abnorm. Psychol. 120, 617–627 (2011).
Phaf, R. H., Mohr, S. E., Rotteveel, M. & Wicherts, J. M. Approach, avoidance, and affect: a meta-analysis of approach-avoidance tendencies in manual reaction time tasks. Front. Psychol. 5, 378 (2014).
Weaver, S. S. et al. Sacrificing reward to avoid threat: Characterizing PTSD in the context of a trauma-related approach-avoidance conflict task. J. Abnorm. Psychol. 129, 457–468 (2020).
Wolgast, M., Lundh, L.-G. & Viborg, G. Experiential avoidance as an emotion regulatory function: an empirical analysis of experiential avoidance in relation to behavioral avoidance, cognitive reappraisal, and response suppression. Cogn. Behav. Ther. 42, 224–232 (2013).
Bonnelle, V. et al. Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being. J. Psychopharmacol. 38, 887–896 (2024).
Monroy, M. & Keltner, D. Awe as a pathway to mental and physical health. Perspect. Psychol. Sci. 18, 309–320 (2023).
Gottlieb, S., Keltner, D. & Lombrozo, T. Awe as a scientific emotion. Cogn. Sci. 42, 2081–2094 (2018).
Keltner, D. & Haidt, J. Approaching awe, a moral, spiritual, and aesthetic emotion. Cognit. Emot. 17, 297–314 (2003).
Lucht, A. & van Schie, H. T. The evolutionary function of awe: A review and integrated model of seven theoretical perspectives. Emot. Rev. 16, 46–63 (2024).
Piff, P. K., Dietze, P., Feinberg, M., Stancato, D. M. & Keltner, D. Awe, the small self, and prosocial behavior. J. Personal. Soc. Psychol. 108, 883–899 (2015).
Rudd, M., Vohs, K. D. & Aaker, J. Awe expands people’s perception of time, alters decision making, and enhances well-being. Psychol. Sci. 23, 1130–1136 (2012).
Russo, M. A., Santarelli, D. M. & O’Rourke, D. The physiological effects of slow breathing in the healthy human. Breathe (Sheff.) 13, 298–309 (2017).
Weiss, B., Wingert, A., Erritzoe, D. & Campbell, W. K. Prevalence and therapeutic impact of adverse life event reexperiencing under ceremonial ayahuasca. Sci. Rep. 13, 9438 (2023).
Griffiths, R. R., Richards, W. A., McCann, U. & Jesse, R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 187, 268–283 (2006).
Kangaslampi, S. Association between mystical-type experiences under psychedelics and improvements in well-being or mental health – A comprehensive review of the evidence. J. Psychedelic Stud. 7, 18–28 (2023).
Ko, K., Knight, G., Rucker, J. J. & Cleare, A. J. Psychedelics, mystical experience, and therapeutic efficacy: A systematic review. Front Psychiatry 13, 917199 (2022).
Yaden, D. B., Goldy, S. P., Weiss, B. & Griffiths, R. R. Clinically relevant acute subjective effects of psychedelics beyond mystical experience. Nat. Rev. Psychol. 3, 606–621 (2024).
Fonkoue, I. T. et al. Eight weeks of device-guided slow breathing decreases sympathetic nervous reactivity to stress in posttraumatic stress disorder. Am. J. Physiol. -Regulatory Integr. Comp. Physiol. 319, R466–R475 (2020).
van Elk, M. & Fried, E. I. History repeating: guidelines to address common problems in psychedelic science. Ther. Adv. Psychopharmacol. 13, 20451253231198466 (2023).